These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21843904)

  • 21. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W; Cheng L; Li B
    Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
    Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
    Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
    Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
    Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination.
    de Bree E; Rosing H; Michalakis J; Romanos J; Relakis K; Theodoropoulos PA; Beijnen JH; Georgoulias V; Tsiftsis DD
    Eur J Surg Oncol; 2006 Aug; 32(6):666-70. PubMed ID: 16618534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy.
    Dwivedi P; Han S; Mangrio F; Fan R; Dwivedi M; Zhu Z; Huang F; Wu Q; Khatik R; Cohn DE; Si T; Hu S; Sparreboom A; Xu RX
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():113-123. PubMed ID: 31146981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.
    Tang QS; Chen DZ; Xue WQ; Xiang JY; Gong YC; Zhang L; Guo CQ
    Int J Nanomedicine; 2011; 6():3077-85. PubMed ID: 22163161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer.
    Jain A; Jain SK
    Drug Dev Ind Pharm; 2016 Jan; 42(1):136-149. PubMed ID: 26006330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of folate-targeted, paclitaxel-loaded polymeric micelles on a human esophageal EC9706 cancer cell line.
    Wu W; Zheng Y; Wang R; Huang W; Liu L; Hu X; Liu S; Yue J; Tong T; Jing X
    Int J Nanomedicine; 2012; 7():3487-502. PubMed ID: 22848173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.
    Corbin IR; Ng KK; Ding L; Jurisicova A; Zheng G
    Nanomedicine (Lond); 2013 Jun; 8(6):875-90. PubMed ID: 23067398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.
    Cirstoiu-Hapca A; Buchegger F; Lange N; Bossy L; Gurny R; Delie F
    J Control Release; 2010 Jun; 144(3):324-31. PubMed ID: 20219607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
    Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
    Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-Targeted and Oxygen/Indocyanine Green-Loaded Lipid Nanoparticles for Dual-Mode Imaging and Photo-sonodynamic/Photothermal Therapy of Ovarian Cancer in Vitro and in Vivo.
    Liu Y; Chen S; Sun J; Zhu S; Chen C; Xie W; Zheng J; Zhu Y; Xiao L; Hao L; Wang Z; Chang S
    Mol Pharm; 2019 Oct; 16(10):4104-4120. PubMed ID: 31517495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [FRα: a target for prophylactic photodynamic therapy of ovarian peritoneal metastasis?].
    Azaïs H; Moussaron A; Khodja Bach S; Bassil A; Betrouni N; Frochot C; Collinet P; Mordon S
    Bull Cancer; 2014 Dec; 101(12):1109-13. PubMed ID: 25532689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest.
    Vallon M; Seidl C; Blechert B; Li Z; Gilbertz KP; Baumgart A; Aichler M; Feuchtinger A; Gaertner FC; Bruchertseifer F; Morgenstern A; Walch AK; Senekowitsch-Schmidtke R; Essler M
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1886-97. PubMed ID: 22872310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
    Wang X; Li J; Wang Y; Koenig L; Gjyrezi A; Giannakakou P; Shin EH; Tighiouart M; Chen ZG; Nie S; Shin DM
    ACS Nano; 2011 Aug; 5(8):6184-94. PubMed ID: 21728341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy.
    Ak G; Yilmaz H; Güneş A; Hamarat Sanlier S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):926-937. PubMed ID: 29458269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.
    Jones SK; Lizzio V; Merkel OM
    Biomacromolecules; 2016 Jan; 17(1):76-87. PubMed ID: 26636884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.